Item 3.02. Unregistered Sales of Equity Securities.
In June 2021, Genufood Energy Enzymes Corp. (the "Company") sold 63,000,000
shares of its common stock to 18 individuals at a purchase price of $0.01 per
share, for gross and net proceeds of $630,000, in an offering that is
continuing. The offering is exempt from the registration provisions of the
Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and
Regulation D and/or Regulation S promulgated thereunder.
Item 8.01 Other Events.
On June 25, 2021, the Company purchased 60,000 shares of Series C Preferred
Stock ("Series C Preferred Shares"), at $10.00 per share, for a total purchase
price of $600,000, from Hukui Biotechnology Corporation, pursuant to that
certain Series C Preferred Shares Subscription Agreement dated September 23,
2020 (the "Hukui Agreement"). As previously reported, pursuant to the Hukui
Agreement, the Company has agreed to purchase an aggregate 200,000 Series C
Preferred Shares, at $10.00 per share, for an aggregate investment of
$2,000,000, in a series of three closings from December 15, 2020 through June
30, 2022. The Company purchased 80,000 Series C Preferred Shares for $800,000 on
December 15, 2020. This is the second such closing under the Hukui Agreement.
1© Edgar Online, source Glimpses
GENUFOOD ENERGY ENZYMES CORP. 
